Evidence map›Paper›PMID 21356373›Full record

ArticleThe American journal of pathology2011

Aligned collagen is a prognostic signature for survival in human breast carcinoma.

Matthew W Conklin, Jens C Eickhoff, Kristin M Riching, Carolyn A Pehlke, Kevin W Eliceiri, Paolo P Provenzano, Andreas Friedl, Patricia J Keely

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 810 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
810citing papers in PubMed, 2 pooled it
15.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

810 citing papers in PubMed, 2 syntheses or guidelines pooled it, 1,276 citations in OpenAlex.

  1. Pooled it
  2. 3DACS biomaterials science & engineering · 2023
    Pooled it
  3. Article
  4. Understanding and targeting the tumour matrisome.Nature reviews. Clinical oncology · 2026
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

750 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 3 countries.

Matthew W ConklinDepartment of Pharmacology, and the Laboratory for Molecular Biology, University of Wisconsin, Madison, Wisconsin 53706, USA.
Jens C Eickhoff
Kristin M Riching
Carolyn A Pehlke
Kevin W Eliceiri
Paolo P Provenzano
Andreas Friedl
Patricia J Keely
University of Wisconsin–Madison · US

Funding

Research Training for Computation and Informatics in Biology and MedicineT15LM007359 · NLM · UNIVERSITY OF WISCONSIN-MADISON · PI Mark W. Craven, Colin Noel Dewey · 2002 to 2026
$22.6M
Mechanisms Of Cell Migration On 3D Aligned MatricesR01CA142833 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI FRIEDL, ANDREAS, HAHN, KLAUS M. · 2010 to 2020
$3.4M
Syndecan-1 in Stromal Fibroblasts of Breast CarcinomasR01CA107012 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI FRIEDL, ANDREAS · 2005 to 2014
$2.8M
Development of The Prairie Technologies MPLSM to image cancer models in vivoR01CA136590 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI CAMPAGNOLA, PAUL J, KEELY, PATRICIA J · 2009 to 2013
$2.4M
A Spectral/Lifetime Microscope for in vivo StudiesR01EB000184 · NIBIB · UNIVERSITY OF WISCONSIN-MADISON · PI WHITE, JOHN GRAHAM · 2002 to 2006
$1.9M
Biophysical Regulation of Breast DifferentiationR01CA114462 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI KEELY, PATRICIA J · 2010 to 2014
$1.5M
Microchannel cell-based assays to enable cancer researchR33CA137673 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI BEEBE, DAVID J · 2009 to 2011
$1.4M
Study of Progenitor Regulation in Mouse Mammary GlandK25CA104162 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI BEEBE, DAVID J · 2004 to 2008
$751k
Using New Optical Techniques to Study Cell Signaling in 3D MatricesR21CA126635 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI KEELY, PATRICIA J · 2008 to 2009
$323k
NCI NIH HHS 2R01 CA107012-06NCI NIH HHS K25 CA104162NCI NIH HHS R01 CA107012NCI NIH HHS R01 CA114462NCI NIH HHS R01 CA136590NCI NIH HHS R01 CA142833NCI NIH HHS R21 CA126635NCI NIH HHS R33 CA137673NIBIB NIH HHS R01 EB000184NLM NIH HHS T15 LM007359
6 · The paper itself

Abstract

Evidence for the potent influence of stromal organization and function on invasion and metastasis of breast tumors is ever growing. We have performed a rigorous examination of the relationship of a tumor-associated collagen signature-3 (TACS-3) to the long-term survival rate of human patients. TACS-3 is characterized by bundles of straightened and aligned collagen fibers that are oriented perpendicular to the tumor boundary. An evaluation of TACS-3 was performed in biopsied tissue sections from 196 patients by second harmonic generation imaging of the backscattered signal generated by collagen. Univariate analysis of a Cox proportional hazard model demonstrated that the presence of TACS-3 was associated with poor disease-specific and disease-free survival, resulting in hazard ratios between 3.0 and 3.9. Furthermore, TACS-3 was confirmed to be an independent prognostic indicator regardless of tumor grade and size, estrogen or progesterone receptor status, human epidermal growth factor receptor-2 status, node status, and tumor subtype. Interestingly, TACS-3 was positively correlated to expression of stromal syndecan-1, a receptor for several extracellular matrix proteins including collagens. Because of the strong statistical evidence for poor survival in patients with TACS, and because the assessment can be performed in routine histopathological samples imaged via second harmonic generation or using picrosirius, we propose that quantifying collagen alignment is a viable, novel paradigm for the prediction of human breast cancer survival.

Indexed as

Biomarkers, TumorBiopsyBreast NeoplasmsCollagenDiagnostic ImagingFemaleHumansMultivariate AnalysisPrognosisRegression AnalysisSurvival AnalysisBiomarkers, TumorCollagen

Identifiers

PMID21356373
PMCPMC3070581
OpenAlexW2101728107

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.